Sarepta Therapeutics Inc (NASDAQ:SRPT) price on current trading day, rose 0.34% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $37.44.
A look at the stock’s price movement, the level at last check in today’s session was $37.31, moving within a range at $36.85 and $38.09. The beta value (5-Year monthly) was 0.6. Turning to its 52-week performance, $173.25 and $34.10 were the 52-week high and 52-week low respectively. Overall, SRPT moved 4.74% over the past month.
Sarepta Therapeutics Inc’s market cap currently stands at around $3.68 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-05.
Analysts have a consensus estimate of 558.94M for the company’s revenue for the quarter, with a low and high estimate of 526.98M and 646.48M respectively. The average forecast suggests up to a 54.01% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.56B, representing a 34.35% jump on that reported in the last financial year.
17 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 6 analyst(s) rate the stock as a Hold, 10 recommend SRPT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SRPT’s current price about -3.09% and -19.73% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.35, while 7-day volatility ratio is 3.07% and 3.83% in the 30-day chart. Further, Sarepta Therapeutics Inc (SRPT) has a beta value of 0.60, and an average true range (ATR) of 2.61. Analysts have given the company’s stock an average 52-week price target of $110, forecast between a low of $110 and high of $110. Looking at the price targets, the low is -193.8% off recent price level in today’s trading while to achieve the yearly target high, it has to move -193.8%. Nonetheless, investors will most likely welcome a -193.8% jump to $110 which is the analysts’ median price.
If we refocus on Sarepta Therapeutics Inc (NASDAQ:SRPT), historical trading data shows that trading volumes averaged 3.22 over the past 10 days and 3.81 million over the past 3 months. The company’s latest data on shares outstanding shows there are 98.25 million shares.
The 4.99% of Sarepta Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 90.14% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.26 million on 2025-05-30, giving us a short ratio of 1.67. The data shows that as of 2025-05-30 short interest in Sarepta Therapeutics Inc (SRPT) stood at 1104.0 of shares outstanding, with shares short rising to 6.7 million registered in 2025-04-30. Current price change has pushed the stock -69.21% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SRPT stock continues to rise going into the next quarter.
